| Trial Identifier: | D0816C00016 |
| Sponsor: | AstraZeneca |
| Start Date: | May 2018 |
| Primary Completion Date: | January 2025 |
| Study Completion Date: | January 2025 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| CN | Beijing, CN, 100142 |
| CN | Changsha, CN, 410013 |
| CN | Chengdu, CN, 610041 |
| CN | Chongqing, CN, 400030 |
| CN | Chongqing, CN, 400038 |
| CN | Hangzhou, CN, 310022 |
| CN | Hangzhou, CN, 310006 |
| CN | Harbin, CN, 150081 |
| CN | Hefei, CN, 230031 |
| CN | Jinan, CN, 250012 |
| CN | shanghai, CN, 200011 |
| CN | Shanghai, CN, 200080 |
| CN | Shanghai, CN, 200032 |
| CN | Shenyang, CN, 110016 |
| CN | Tianjin, CN, 300060 |
| CN | Tianjin, CN, 300100 |
| CN | Wuhan, CN, 430079 |
| CN | Wuhan, CN, 430030 |
| CN | Xian, CN, 710061 |
| CN | Zhengzhou, CN, 450008 |
| MY | Ampang, MY, 68000 |
| MY | Johor Bahru, MY, 81100 |
| MY | Kuala Lumpur, MY, 59100 |
| MY | Kuching, MY, 93586 |
| MY | Putrajaya, MY, 62250 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company